Juliana Rollo
Family · Madison, WVNPI 1083338875
Payments from drug & device makers
Across 126 payments — averaging $21.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$474
- AbbVie$417
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$404
- Alkermes, Inc.$261
- Teva Pharmaceuticals USA, Inc.$258
- Lundbeck LLC$238
- plus $668 from 11 others
What the payments were for
- Food & beverage$2,720100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $474 |
| AbbVie | 22 | $417 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $404 |
| Alkermes, Inc. | 15 | $261 |
| Teva Pharmaceuticals USA, Inc. | 13 | $258 |
| Lundbeck LLC | 13 | $238 |
| Vanda Pharmaceuticals Inc. | 8 | $191 |
| Johnson & Johnson | 6 | $135 |
| E.r. Squibb & Sons, L.L.C. | 5 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Bayer | 3 | $46 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Indivior Inc. | 1 | $17 |
| Exact Sciences | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABILIFY ASIMTUFII$230
- ABILIFY MAINTENA$230
- REXULTI$124
- CAPLYTA$100
How this compares
$2,720 in reported general payments places this provider in the 80th percentile of 1,507 family providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 26 | $46,318 |
| RexultiBrexpiprazole | 23 | $38,899 |
| TrintellixVortioxetine Hydrobromide | 13 | $6,218 |
| Clomipramine Hcl | 28 | $1,450 |
| Duloxetine Hcl | 39 | $451 |
| Aripiprazole | 46 | $446 |
| Buspirone Hcl | 45 | $416 |
| Oxcarbazepine | 14 | $404 |
| Sertraline Hcl | 28 | $351 |
| Trazodone Hcl | 46 | $314 |
| Quetiapine Fumarate | 37 | $303 |
| Hydroxyzine Hcl | 12 | $283 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 39 | $276 |
| Alprazolam | 63 | $243 |
| Bupropion XlBupropion Hcl | 20 | $242 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $417 | $46,31826 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $474 | $38,89923 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $51 | $6,21813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,507 family providers in West Virginia.
Other family in Madison
- Brittany GriffithMadison$8K
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
- Angela SettleCharleston$51K
- Amber DuncanCross Lanes$44K
- Jennifer FieldsHuntington$32K
- Gina LatheyScott Depot$31K
- Jodi BillerScott Depot$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.